Register
Supercharging cancer cells mutation rate could create a vaccine |
Clinical News
eMediNexus Coverage from: 
Supercharging cancer cells mutation rate could create a vaccine
eMediNexus,  10 February 2020
remove_red_eye 544 Views
#Business And Medicine #Pathology and Lab Medicine #Public Health

1 Read Comments                

London: Supercharging the mutation rate in cancer cells could create a powerful vaccine that can boost the effectiveness of immunotherapy, suggests a new study published in the journal Nature Communications.

Scientists forced cancer cells in the lab to evolve much more rapidly than usual with the help of a molecule called APOBEC3B, often used by tumors to drive rapid genetic change and drug resistance. These highly mutated cancer cells could be used to create a vaccine for each individual cancer type, which enhanced the effects of immunotherapy and cured mice with some otherwise treatment-resistant tumors, revealed the study… (ET Healthworld – IANS, February 9, 2020)

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now